# thymulin FAQ: 24 Questions from the Research Literature

> thymulin frequently asked questions — mechanism, zinc dependency, dosage range, thymalin vs thymulin, hair follicle research, and more. Direct answers cited from the peer-reviewed literature.

## thymulin: Frequently Asked Questions

Indexed questions from peer-reviewed literature, public questions, and community research discussions. Every quantitative answer cites a source in the references index.

## Questions and Answers

**What is thymulin?**
A nine-amino-acid (nonapeptide) hormone secreted by thymic epithelial cells, thymulin acts as a circulating immune signal for T-lymphocyte maturation and cytokine regulation. Its full scientific name is Facteur Thymique Serique (FTS). Molecular weight: 858.8 Da. Sequence: Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn. It requires zinc to function [1, 3].

**What is thymulin peptide used for?**
In published research, thymulin is studied for T-lymphocyte maturation, immune modulation, anti-inflammatory cytokine balance, analgesic effects, and — in preclinical models — neuroprotection and hair follicle stimulation. It is not approved for human therapeutic use in any jurisdiction [3, 6, 7, 17].

**What is the drug thymulin?**
thymulin is not an approved drug. It is an endogenous nonapeptide hormone produced by the thymus and, in synthetic form, a research compound. No Phase 2 or Phase 3 clinical trials of synthetic thymulin are registered on ClinicalTrials.gov. No FDA IND or NDA has been identified for the compound [18].

**What organs produce thymulin?**
thymulin is produced exclusively by the epithelial cells of the thymus — specifically the reticulo-epithelial cell population. No other organ is a physiological source. After thymectomy, circulating thymulin disappears [3].

**Does thymulin decline with age?**
Thymulin titres peak in children aged 5–10 years (mean titre 4.77) and progressively fall from adolescence, reaching a nadir at age 36 (mean titre 0.66) that remains stable through age 80 [2]. The age-related decline involves both thymic involution and reduced zinc saturation of circulating thymulin peptide [5].

**What does thymulin do?**
thymulin induces T-cell differentiation by promoting CD2, CD3, CD4, and CD8 surface-marker expression on thymocyte precursors [3]. It also enhances NK cell activity at low doses [10], modulates cytokine production by suppressing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ [9], stimulates pituitary hormone release [11], and attenuates inflammatory and neuropathic pain signaling via NF-kB and MAPK pathway inhibition [6, 13]. All these effects require zinc [1].

**What does thymuline do?**
Thymuline is an alternate spelling of thymulin — the same compound. It promotes T-cell maturation and requires zinc for its active conformation. The zinc-bound form (Zn-FTS) is the active species [1, 3].

**Are there side effects associated with thymulin?**
Preclinical models report minimal adverse effects at studied concentrations [9, 13, 17]. Human safety data are limited. A noteworthy preclinical signal: low-dose thymulin enhanced NK cytotoxicity while high-dose thymulin suppressed it — a bidirectional dose-response [10].

**What are the benefits of thymulin peptide?**
Studies in rodent and ex-vivo models report: immune reconstitution via T-cell maturation, reduction of pro-inflammatory cytokines, analgesic effects comparable to NSAID comparators in rodent pain models, neuroprotective effects in EAE autoimmune models, and — in a small open-label human pilot — 32% increase in vellus hairs and 23% increase in intermediate hairs with topical zinc-thymulin [6, 9, 13, 17].

**What is the difference between thymulin and thymalin?**
thymulin is a single defined nine-amino-acid endogenous hormone (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) whose bioactivity requires zinc. Thymalin is a polypeptide complex extracted from bovine thymus glands, used primarily in Russian bioregulator research. The two are related by origin (both thymic) but distinct in composition [16].

**Thymulin vs Thymalin: How Do They Differ?**
Composition: thymulin is a single, sequenced nine-amino-acid peptide. Thymalin is a polypeptide mixture extracted from bovine thymus tissue. Mechanism: thymulin acts via defined T-cell receptor-mediated differentiation signaling requiring zinc. Thymalin's effects are attributed to a mixture of thymic peptides with less-characterized pharmacology. Research base: thymulin has a cleaner mechanistic literature; thymalin has a longer Russian clinical history, including a 6-year mortality study [16].

**Is thymulin the same peptide as thymalin?**
No. They share a thymic origin but differ in composition, mechanism, research base, and regulatory history [16].

**What is the studied dosage range for thymulin in preclinical models?**
The range spans from picomolar concentrations (0.5–50 pM in vitro pituitary assays [11]) to milligram-per-kilogram doses (1.5 mg/kg IP in the nanoparticle EAE study [13]). In rodent pain models, the PAT analogue was used at 0.25–200 μg/rat IP. No validated human dosing protocol exists.

**Does zinc-thymulin actually work for hair growth?**
A pilot open-label study (n=18, androgenetic alopecia, Norwood 2–7) associated topical zinc-thymulin with a 32% mean increase in vellus hairs and a 23% increase in intermediate hairs at 6 months [17]. The study lacks a placebo control and has a small sample size. It is the only published human efficacy signal for zinc-thymulin in hair.

**How does the Epitalon and thymulin stack affect deep sleep?**
No controlled human data on thymulin-epitalon effects on sleep architecture exist in peer-reviewed literature. The Russian mortality data uses thymalin (bovine polypeptide extract), not the defined thymulin nonapeptide [16].

**What are the effects of running thymulin subcutaneously for 30 days?**
No specific 30-day subcutaneous protocol was identified in the indexed peer-reviewed record. The most comparable rodent protocol is the 25-day every-other-day IP nanoparticle EAE study [13]. Extrapolation from rodent IP data to human subcutaneous outcomes is not supported by controlled trial data.

**Has thymulin been studied in long COVID or vaccine-related immune conditions?**
Thymalin (bovine thymic polypeptide extract) was studied in severe COVID-19 in Russian clinical research — not the defined thymulin nonapeptide. thymulin itself has not been evaluated in post-COVID or vaccine-related immune conditions in published controlled trials.

## References

[1] Dardenne M, Pleau JM. Interactions Between Zinc and Thymulin. Metal-Based Drugs. 1994;1(4):233-249. DOI: 10.1155/MBD.1994.233
[2] Consolini R, et al. Distribution of age-related thymulin titres. Clin Exp Immunol. 2000;121(3):444-7. DOI: 10.1046/j.1365-2249.2000.01315.x
[3] Reggiani PC, et al. The Thymus-Neuroendocrine Axis. Ann N Y Acad Sci. 2009;1153:98-106. DOI: 10.1111/j.1749-6632.2008.03964.x
[4] Prasad AS, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82(4):1202-10. DOI: 10.1172/JCI113717
[5] Mocchegiani E, Fabris N. Age-related thymus involution: zinc reverses the thymulin secretion defect. Int J Immunopharmacol. 1995;17(9):745-9. DOI: 10.1016/0192-0561(95)00064-9
[6] Safieh-Garabedian B, et al. Potent analgesic and anti-inflammatory actions. Br J Pharmacol. 2002;136(7):947-55. DOI: 10.1038/sj.bjp.0704793
[7] Saade NE, et al. A thymulin analogue peptide with powerful inhibitory effects on pain. Neuroscience. 2003;119(2):529-40. DOI: 10.1016/s0306-4522(03)00072-1
[8] Safieh-Garabedian B, et al. Thymulin reverses inflammatory hyperalgesia. Neuroscience. 2003;122(4):1049-61. DOI: 10.1016/s0306-4522(03)00500-1
[9] Lunin SM, et al. Thymulin prevents the overproduction of pro-inflammatory cytokines. Immunol Invest. 2008;37(8):858-71. DOI: 10.1080/08820130802447629
[10] Oliver MA, Marsh JA. In vivo thymulin treatments enhance avian NK cell cytotoxicity. Int Immunopharmacol. 2003;3(3):271-80. DOI: 10.1016/s1567-5769(02)00236-9
[11] Hadley AJ, et al. Thymulin stimulates corticotrophin release. Neuroimmunomodulation. 1997;4(2):62-9. DOI: 10.1159/000097322
[12] Reggiani PC, et al. Gene therapy for long-term restoration of circulating thymulin. Gene Ther. 2006;13(16):1214-21. DOI: 10.1038/sj.gt.3302775
[13] Lunin SM, et al. Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against Relapsing-Remitting EAE. Int J Mol Sci. 2019;20(21):5374. DOI: 10.3390/ijms20215374
[14] Wise T, Ford JJ. Effects of thymulin on testicular steroid concentrations. J Anim Sci. 1999;77(8):2240-51. DOI: 10.2527/1999.7782240x
[16] Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-40.
[17] Vickers ER. An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia. Hair Ther Transplant. 2017;7:147. DOI: 10.4172/2167-0951.1000147
[18] Reggiani PC, et al. Physiology and therapeutic potential of the thymic peptide thymulin. Curr Pharm Des. 2014;20(29):4690-6. DOI: 10.2174/1381612820666140130211157

---

A machinist's indexed reference for the zinc-thymulin record — mechanism assembled part by part from the published literature, no clinic behind the rivets.